Uncategorized - June 14, 2016
Multi-million commitment to innovative production of biologics
The Swedish Industry and Innovation Minister, Mikael Damberg, notified last Thursday an upcoming commitment to innovative production of biopharmaceuticals within the framework of the life science collaboration program. “The government is contributing with 90 million SEK in order to create an unique innovation environment which will overcome the important shift from research to industrial production […]
Agreement - May 15, 2016
GE Healthcare and Uppsala BIO form a new partnership
GE Healthcare Life Sciences signs a two-year collaboration agreement with Uppsala BIO. The goal is to find technologies and equipment that support the production and processing of biopharmaceuticals in the future. “Although we are a large, international company, it is rare that we form this type of active technology scouting partnerships”, says Jonas Åström, Head […]
Agreement - March 14, 2016
New co-marketing deal for AMRA
AMRA has entered into a new co-marketing agreement with GE Healthcare. AMRATM Profiler protocol will be made available on future GE Healthcare MRI scanners. AMRATM Profiler is a cloud-based body composition measurement service, which uses images from a rapid, 6-minute MRI scan to deliver fat and muscle measurements. It introduces new standards in body composition measurement […]
Agreement - October 16, 2015
C-RAD signs agreement with GE
GE Healthcare has entered into a sales and distribution agreement for C-RAD’s Sentinel 4DCT™ systems and Cyrpa High Impact Technology (HIT) laser systems. C-RAD’s systems are used for 4D imaging and virtual simulation in radiation therapy. GE will offer these solutions through its price book, making them available to the GE salesforce and their customers […]
Agreement - December 8, 2014
SyntheticMR signs license agreement with GE Healthcare
SyntheticMR has entered into a license agreement with GE Healthcare regarding SyMRI IMAGE. The agreement gives GE the right to sell a customized version of SyntheticMR’s software directly to its customers globally. GE Healthcare is now introducing the software, which is marketed under the name MAGiC, at RSNA. In the quarterly report for the second […]
Global report - September 5, 2014
GE Healthcare gets EU approval of VIZAMYL
VIZAMYL has received marketing authorisation from the European Commission for PET imaging of beta amyloid plaque in suspected Alzheimer’s disease. It will be commercially available in selected European countries from early 2015. When used in conjunction with a clinical evaluation, using VIZAMYL to detect the accumulation of beta amyloid in the brain may help to confirm an Alzheimer’s […]
